Rodriguez-Garcia, Alba http://orcid.org/0000-0003-0906-1793
Lynn, Rachel C.
Poussin, Mathilde
Eiva, Monika A.
Shaw, Lauren C.
O’Connor, Roddy S.
Minutolo, Nicholas G.
Casado-Medrano, Victoria
Lopez, Gonzalo http://orcid.org/0000-0002-5092-1284
Matsuyama, Takami
Powell, Daniel J. Jr. http://orcid.org/0000-0002-5966-8908
Article History
Received: 27 April 2020
Accepted: 22 December 2020
First Online: 9 February 2021
Competing interests
: D.J.P. and the University of Pennsylvania hold published patents on the use of human FRβ-specific (US20140286973A1) and mesothelin-specific chimeric antigen receptors (WO2015090230A1). An FRβ-specific CAR (US20140286973A1) is the subject of a licensing agreement between the University of Pennsylvania and Tmunity Therapeutics. These CARs are designed for potential application in human subjects. The CL10 FRβ-specific CAR applied in this manuscript is not covered by the patent application. The other authors declare no competing interests.